Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
23/12/2024 | 23:01 | GlobeNewswire Inc. | Ashland signs definitive agreement to sell Avoca business to Mane | NYSE:ASH | Ashland Inc |
09/12/2024 | 23:15 | Edgar (US Regulatory) | Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] | NYSE:ASH | Ashland Inc |
09/12/2024 | 23:15 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NYSE:ASH | Ashland Inc |
09/12/2024 | 23:01 | GlobeNewswire Inc. | Ashland rings opening bell at NYSE recognizes 100-year anniversary | NYSE:ASH | Ashland Inc |
09/12/2024 | 22:09 | Edgar (US Regulatory) | Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material | NYSE:ASH | Ashland Inc |
09/12/2024 | 22:05 | Edgar (US Regulatory) | Form DEF 14A - Other definitive proxy statements | NYSE:ASH | Ashland Inc |
09/12/2024 | 22:05 | Edgar (US Regulatory) | Form ARS - Annual Report to Security Holders | NYSE:ASH | Ashland Inc |
09/12/2024 | 12:30 | GlobeNewswire Inc. | Ashland celebrates solvers, recognizes 100 years of innovation by planting trees to restore local ecosystems and support sustainable sourcing | NYSE:ASH | Ashland Inc |
06/12/2024 | 22:28 | Edgar (US Regulatory) | Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] | NYSE:ASH | Ashland Inc |
05/12/2024 | 15:53 | Edgar (US Regulatory) | Form 144 - Report of proposed sale of securities | NYSE:ASH | Ashland Inc |
25/11/2024 | 23:00 | Edgar (US Regulatory) | Form 8-K - Current report | NYSE:ASH | Ashland Inc |
18/11/2024 | 22:33 | Edgar (US Regulatory) | Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] | NYSE:ASH | Ashland Inc |
14/11/2024 | 13:00 | GlobeNewswire Inc. | Ashland board authorizes quarterly dividend | NYSE:ASH | Ashland Inc |
08/11/2024 | 13:00 | GlobeNewswire Inc. | Ashland to host live 2024 strategy update event for analysts and investors | NYSE:ASH | Ashland Inc |
06/11/2024 | 23:00 | GlobeNewswire Inc. | Ashland reports financial results for fourth-quarter fiscal 20241, issues outlook for full-year fiscal 2025, provides portfolio optimization update and announces strategy update event | NYSE:ASH | Ashland Inc |
28/10/2024 | 22:00 | GlobeNewswire Inc. | Ashland sets date for fourth-quarter fiscal 2024 earnings release and conference call webcast | NYSE:ASH | Ashland Inc |
16/09/2024 | 13:00 | GlobeNewswire Inc. | Ashland accelerates application of super wetting technology, commercializes superior wetting agent for corn, soy, wheat, watermelon, other produce and florals | NYSE:ASH | Ashland Inc |
03/09/2024 | 13:00 | GlobeNewswire Inc. | Ashland completes sale of nutraceuticals business | NYSE:ASH | Ashland Inc |
13/08/2024 | 22:30 | Edgar (US Regulatory) | Form 3 - Initial statement of beneficial ownership of securities | NYSE:ASH | Ashland Inc |
06/08/2024 | 23:01 | GlobeNewswire Inc. | Ashland reports financial results1 for third quarter fiscal 2024, issues outlook for fourth quarter and full-year fiscal 2024 | NYSE:ASH | Ashland Inc |
17/07/2024 | 13:00 | GlobeNewswire Inc. | Ashland sets date for fiscal 2024 third-quarter earnings release and conference call webcast | NYSE:ASH | Ashland Inc |
24/06/2024 | 13:00 | GlobeNewswire Inc. | Ashland announces strategy, mergers and acquisitions, and portfolio management leader | NYSE:ASH | Ashland Inc |
18/06/2024 | 13:00 | GlobeNewswire Inc. | Ashland achieves certification by Fair Wage Network | NYSE:ASH | Ashland Inc |
04/06/2024 | 14:00 | GlobeNewswire Inc. | Ashland announces Life Sciences business leader | NYSE:ASH | Ashland Inc |
23/05/2024 | 23:12 | Edgar (US Regulatory) | Form 11-K - Annual report of employee stock purchase, savings and similar plans | NYSE:ASH | Ashland Inc |
08/05/2024 | 23:01 | GlobeNewswire Inc. | Ashland Board appoints Ashish K. Kulkarni as new director | NYSE:ASH | Ashland Inc |
07/05/2024 | 13:00 | Business Wire | Turnspire Capital Partners to Acquire Ashland Nutraceuticals Business | NYSE:ASH | Ashland Inc |
07/05/2024 | 12:59 | GlobeNewswire Inc. | Ashland signs definitive agreement to sell nutraceuticals business to Turnspire Capital Partners | NYSE:ASH | Ashland Inc |
30/04/2024 | 23:01 | GlobeNewswire Inc. | Ashland reports financial results1 for second quarter fiscal 2024; issues outlook for third quarter and full-year fiscal 2024 | NYSE:ASH | Ashland Inc |
18/04/2024 | 12:59 | GlobeNewswire Inc. | Ashland sets date for fiscal 2024 second-quarter earnings release and conference call webcast | NYSE:ASH | Ashland Inc |